Rock Springs Capital Management LP Pliant Therapeutics, Inc. Transaction History
Rock Springs Capital Management LP
- $2.51 Billion
- Q4 2024
A detailed history of Rock Springs Capital Management LP transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 404,796 shares of PLRX stock, worth $546,474. This represents 0.21% of its overall portfolio holdings.
Number of Shares
404,796
Previous 384,996
5.14%
Holding current value
$546,474
Previous $4.32 Million
23.55%
% of portfolio
0.21%
Previous 0.15%
Shares
3 transactions
Others Institutions Holding PLRX
# of Institutions
175Shares Held
64.8MCall Options Held
228KPut Options Held
772K-
Deep Track Capital, LP Greenwich, CT5.97MShares$8.06 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$6.71 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.63MShares$6.26 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$4.36 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.2MShares$4.32 Million1.61% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $65.7M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...